Profile of individuals with full-scale intelligence quotient (FSIQ) scores in the National Spina Bifida Patient Registry (NSBPR) Authors: Heidi Castillo, Sophia Drewry, Amy Heffelfinger, Jennifer T Queally, Kurt A Freeman, Vanessa Avemil, Richard Adams, Pamela Murphy, Kathryn Smith, Audrey Roach, Gregory Heuer, William Walker, Jonathan Castillo, Catharine Riley Published: 2026 ABSTRACT AbstractPurposeAlthough intelligence quotient (IQ) testing can help identify cognitive issues, data on IQ testing in the spina bifida (SB) population is limited and difficult to collect. This study aimed to identify factors influencing IQ test reporting among individuals in the National Spina Bifida Patient Registry (NSBPR).MethodsA descriptive analysis of 1,017 individuals aged 4 to 22 years from five NSBPR clinics was conducted. Characteristics of participants with a full-scale intelligence quotient (FSIQ) score (n=435) were compared to those without (n=582). Multivariable logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to determine the likelihood of having an FSIQ score, adjusting for sex, race, ethnicity, insurance status, functional level of lesion, and clinic.ResultsIndividuals who received full-time (OR=1.83, 95% CI: 1.16, 2.88) or some (OR=1.97, 95% CI: 1.38, 2.82) academic accommodations were more likely to have an FSIQ score. The mean age at IQ testing was 9.7 years (SD: 4.0), and mean FSIQ score was 81.3 (SD: 16.9).ConclusionHistory of academic accommodation was associated with having FSIQ scores. Average FSIQ score was lower than the normative population, highlighting the need for broader testing and care among people with SB.Keywords: spina bifida, myelomeningocele, cognition, intelligence, neuropsychology Introduction Spina bifida (SB) is the most common birth defect affecting the central nervous system, with a prevalence of approximately three per 10,000 live births. 1 This anomaly occurs within the first 28 days of pregnancy when the neural tube fails to develop or close properly. Public health initiatives such as folic acid fortification and supplementation have decreased the prevalence of SB at birth.2,3 Additionally, medical innovations such as prenatal neural tube closure have decreased the incidence of associated conditions, including hydrocephalus and Chiari II malformation.4,5 Despite these advances, individuals with SB may experience more adverse intellectual and cognitive outcomes compared to peers without SB.6,7 Previous studies indicate that individuals with SB can have lower intelligence quotient (IQ) scores than those without SB, although the range and presentation of cognitive impairment may differ. 8 Key areas where differences are observed include processing speed, visual motor integration, attention, and executive functions such as abstract reasoning.9–11 Several factors can influence neurocognitive outcomes, including the level of SB lesion, hydrocephalus, shunt placement, structural brain anomalies, epilepsy, and the type of closure procedure performed.12–15 Therefore, individuals with SB can have considerable cognitive difficulties that profoundly impact learning, social development, daily living skills, employment, and autonomy, which in turn affect participation in activities across their lifespan. 16 Neurocognitive testing is important for individuals with SB as it helps identify potential intellectual and learning issues and can inform medical, psychosocial, and educational interventions. Repeated evaluations can reveal the effects of changes in brain development and monitor progress following surgical intervention. Incorporating neurocognitive testing supports a comprehensive approach to patient care and enhances multidisciplinary collaboration. However, access to neurocognitive evaluations in clinical settings is often limited due to referral challenges. The Spina Bifida Association’s (SBA) Neuropsychological Guideline for the Care of People with Spina Bifida recommends evaluation at multiple timepoints throughout the lifespan. Still, limited access to these services may hinder implementation. 17 Investigating neurocognitive outcomes in individuals with SB has been challenging due to small sample sizes and lack of neurocognitive data in existing studies. The National Spina Bifida Patient Registry (NSBPR) provides a unique opportunity to analyze IQ testing data in this population. 18 This analysis aims to describe the sociodemographic and clinical characteristics of individuals with and without a full-scale intelligence quotient (FSIQ) score. Understanding the factors that are associated with IQ testing can help identify barriers to regular screening and inform targeted interventions to improve access to neurocognitive assessments for individuals with SB. Methods Study design and population A descriptive study was conducted using data from the NSBPR, a multicenter registry of SB specialty clinics across the United States supported by the Centers for Disease Control and Prevention. Each participating site obtains approval from the local institutional review board (IRB), and all participants provide written consent prior to enrollment. Data collection and management procedures for the NSBPR are standardized and have been previously described. 18 Briefly, participating clinics collect sociodemographic and clinical data at enrollment and during annual visits, based on information provided by participants, caregivers, physicians, and medical records. In November 2019, NSBPR sites began collecting data on 1) whether an individual had undergone IQ testing, 2) the results of IQ testing (FSIQ score), and 3) the age at which the testing was conducted. The FSIQ is a composite score that measures overall cognitive ability and summarizes performance across several cognitive domains. 19 It is derived from various intelligence tests, including the Wechsler Preschool and Primary Scale of Intelligence, Wechsler Intelligence Scale for Children, Wechsler Adult Intelligence Scale, Differential Ability Scales, and Kaufman Brief Intelligence Test. Study sample Data for this study were obtained from the NSBPR from November 2019 to December 2022 (Figure 1). There were 703 patients with FSIQ data. Patients were excluded if they were missing FSIQ scores (n=48) or test dates (n=136), under the age of four (n=12), or from a clinic that does not regularly submit FSIQ data (n=72). Among the 11,109 patients without cognitive data, those who were not enrolled in a clinic that regularly submits FSIQ data (n=4,132), those whose only visits occurred when they were younger than four or older than 22 years (n=5,771), and those whose visits occurred before the NSBPR began collecting FSIQ data (n=624) were excluded. The sample of participants with FSIQ scores was limited to those aged four or older at the time IQ testing was completed, as intelligence testing prior to this age is not as predictive of long-term functioning. 20 Individuals without an FSIQ score were also limited by age between four and 22 years to facilitate meaningful comparisons between those with and without FSIQ scores. Not all NSBPR sites collected IQ testing data during the study period; therefore, the analysis focused on sites that regularly reported FSIQ data, defined as those contributing more than 5% of the total FSIQ scores in the NSBPR. This criterion ensured sites had the capacity to regularly collect and report FSIQ data. Among the 20 NSBPR clinics that regularly collected data during the study period, five met this criterion. For individuals with multiple FSIQ scores, the score from their most recent visit was used. Inclusion and exclusion criteria of individuals with and without full-scale intelligence quotient (FSIQ) score in the National Spina Bifida Patient Registry (NSBPR). Study variables Sociodemographic variables included age, sex, race, ethnicity, insurance type, history of academic accommodation, Child Opportunity Index (COI) quantiles, 21 and clinic site. Race and ethnicity were categorized as non-Hispanic White, non-Hispanic Black, Hispanic or Latino, and other (including Asian, Multiracial, Native Hawaiian, Pacific Islander, and American Indian or Alaskan Native). Insurance type was categorized as either private or non-private (public only, supplementary with and without public, and uninsured). History of academic accommodation was defined as whether an individual had ever received academic accommodations or special education services (full-time, some, or none) in school, with the highest level used when multiple instances were reported. The COI is a composite measure of 29 indicators of factors that affect children’s development, including education, health, environment, and socio-economic resources, assessed by zip code. 21 The COI is categorized into five quantiles: very low (0%–20%), low (20%–40%), moderate (40%–60%), high (60%–80%), and very high (80%–100%), with higher values indicating better conditions for children’s development. COI quantiles were linked to participant residential zip code in four of the five sites, as one site did not have IRB approval to collect participant zip code. Clinical variables included FSIQ score, age at IQ testing, SB type (myelomeningocele or non-myelomeningocele), functional level of lesion (classified as thoracic, high-lumbar, mid-lumbar, low-lumbar, or sacral based on the more severely affected side), and ambulatory status (categorized as community ambulator, household ambulator, therapeutic ambulator, or non-ambulator). Neurosurgical variables included history of prenatal closure, shunt surgery, shunt revision, shunt infection, Chiari II decompression, and endoscopic third ventriculostomy. Statistical analysis The sociodemographic and clinical characteristics of individuals with an FSIQ score were compared to those without. For those with an FSIQ score, data was analyzed from the time of their IQ test; for those without, data from their most recent visit was used. Due to the age distribution of the sample and differing definitions of age between the two groups, age was stratified into two cohorts: 4-10 years and 11-22 years; potential differences among these groups were examined. The Wilcoxon rank sum test, Pearson’s chi-squared test, and Fisher’s exact test were used for group comparisons. Multivariable logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to assess the likelihood of having an FSIQ score, adjusting for sex, race and ethnicity, insurance type, history of academic accommodations, level of lesion, history of shunt, and clinic. Model covariates such as sex, race and ethnicity, insurance type, level of lesion, and clinic were determined a priori, whereas other covariates such as academic accommodations and history of shunt were included if they were significantly associated with the outcome of having an FSIQ score. Variables with a high degree of collinearity with another variable were excluded (i.e., shunt infection was excluded because it was highly correlated with a history of shunt). Age-stratified models were also conducted to examine potential differences among age groups. Among those with a reported IQ test, the distributions of age at reported FSIQ evaluation and FSIQ score were calculated. Additionally, a sub-analysis among individuals with multiple FSIQ scores was conducted to assess changes between the first and second scores, using a paired Student’s t-test. All hypothesis tests were considered significant at p < 0.05. Data were analyzed using R statistical software (version 4.3.3). Results In the analytic sample, a total of 435 individuals (42.7%) had an FSIQ score, while 582 (57.3%) did not (Table 1). Differences were observed between these two groups in age distribution, SB type, history of academic accommodations, functional level of lesion, history of shunt surgery, and history of shunt infection. The mean age of individuals with FSIQ data was 9.7 years, significantly lower than the 11.2 years for those without FSIQ scores (p <0.001). A higher proportion of individuals with FSIQ scores were aged 4-10 years (63%) compared to those without an FSIQ score (49%) (p <0.001). Regarding SB type, 89% of individuals with FSIQ scores were diagnosed with myelomeningocele, compared to 81% of those without FSIQ scores (p <0.001). Additionally, individuals with FSIQ scores were more likely than those without FSIQ scores to have a history of some (56% vs. 43%) or full-time (21% vs. 20%) academic accommodations (p <0.001). There was a significant difference in the functional level of lesion between the two groups (p <0.001). While individuals with FSIQ data had a slightly higher proportion of having a shunt (67% vs. 60%) and history of shunt revision (20% vs 16%), only having a shunt was found to be significant (p = 0.018). Among those with a shunt surgery, shunt infections were more frequently reported among individuals without FSIQ data than those with FSIQ data (9.4% vs. 3.7%, p=0.015), though this subset was small. Other sociodemographic and clinical factors were not notably different between the groups. Table 1.Sociodemographic and clinical characteristics among individuals with and without a full-scale intelligence quotient (FSIQ) score in the National Spina Bifida Patient Registry (N = 1,017).Characteristics n (%) or statisticsFSIQ N = 435No FSIQ N = 582 a p-value b Sociodemographic characteristics Age (years), mean (SD)9.7 (4.0)11.2 (5.4)<.001** Age group <.001** 4-10 years274 (63)286 (49)​ 11-22 years161 (37)296 (51)​ Sex .55 Female231 (53)320 (55)​ Male204 (47)262 (45)​ Race and ethnicity .13 Non-Hispanic White278 (64)397 (68)​ Non-Hispanic Black29 (6.7)42 (7.2)​ Hispanic or Latino93 (21)91 (16)​ Other c 35 (8.0)52 (8.9)​ Insurance type .28 Any private227 (55)297 (51)​ Non-private d 186 (45)280 (49)​ Unknown225​ History of academic accommodations e <.001** None88 (23)184 (37)​ Some214 (56)218 (43)​ Full-time82 (21)102 (20)​ Unknown5178​ Child Opportunity Index f .84 Very Low78 (20)83 (18)​ Low87 (22)110 (24)​ Moderate70 (18)82 (18)​ High75 (19)75 (17)​ Very High86 (22)100 (22)​ Unknown39132​ Clinical characteristics Spina bifida type <.001** Myelomeningocele388 (89)473 (81)​ Non-myelomeningocele47 (11)109 (19)​ Functional level of lesion <.001** Thoracic32 (7.4)93 (16)​ High-lumbar57 (13)45 (7.7)​ Mid-lumbar165 (38)185 (32)​ Low-lumbar70 (16)64 (11)​ Sacral111 (26)195 (34)​ Ambulatory status .16 Non-ambulators109 (25)179 (31)​ Therapeutic ambulators34 (7.8)33 (5.7)​ Household ambulators39 (9.0)46 (7.9)​ Community ambulators253 (58)324 (56)​ Prenatal closure 31 (7.1)41 (7.0).96 History of shunt surgery 293 (67)350 (60).018** History of shunt revision g 88 (20)94 (16).092 Number of shunt revisions h .83 151 (58)56 (60)​ 219 (22)22 (23)​ ≥ 318 (20)16 (17)​ History of shunt infection g,i 11 (3.7)33 (9.4).015** History of Chiari II malformation decompression surgery 36 (8.3)46 (7.9).83 History of endoscopic third ventriculostomy 27 (6.2)30 (5.2).47Note. All clinical variables are pulled up until date of IQ test for those with FSIQ score. Last visit date for annual visit (cutoff at age 22) was used for patients without an FSIQ score.aParticipants who attend clinics that regularly contribute FSIQ score data, restricted for age.bWilcoxon rank sum test; Pearson’s chi-squared test; Fisher’s exact test.cOther race/ethnicity includes Asian, Multiracial, Native Hawaiian or Pacific Islander, and American Indian or Alaskan Native.dNon-private insurance includes public only, supplementary with or without public insurance, and uninsured.eHighest level of academic accommodations ever reported; “None” refers to patient in all typical/regular education.fChild Opportunity Index variable was derived from patient zip code; zip code data available for four of the five sites.gNumber of shunt revisions in the last five years.hAmong patients who had a history of shunt revision.iAmong patients who had a history of shunt surgery. Sociodemographic and clinical characteristics among individuals with and without a full-scale intelligence quotient (FSIQ) score in the National Spina Bifida Patient Registry (N = 1,017). Note. All clinical variables are pulled up until date of IQ test for those with FSIQ score. Last visit date for annual visit (cutoff at age 22) was used for patients without an FSIQ score. aParticipants who attend clinics that regularly contribute FSIQ score data, restricted for age. bWilcoxon rank sum test; Pearson’s chi-squared test; Fisher’s exact test. cOther race/ethnicity includes Asian, Multiracial, Native Hawaiian or Pacific Islander, and American Indian or Alaskan Native. dNon-private insurance includes public only, supplementary with or without public insurance, and uninsured. eHighest level of academic accommodations ever reported; “None” refers to patient in all typical/regular education. fChild Opportunity Index variable was derived from patient zip code; zip code data available for four of the five sites. gNumber of shunt revisions in the last five years. hAmong patients who had a history of shunt revision. iAmong patients who had a history of shunt surgery. Among individuals with FSIQ scores, the majority underwent IQ testing between the ages of seven and 13 years (Figure 2). In the multivariable logistic regression model (Table 2), among the total analytic sample, individuals with a history of some (OR=1.97, 95% CI: 1.38, 2.82) or full-time (OR=1.83, 95% CI: 1.16, 2.88) academic accommodation were more likely to have an FSIQ score than those who had no history of academic accommodation. This association was consistent when stratified by age group, although the association was not significant for full-time academic accommodation among those aged 4-10 years. Individuals with mid-lumbar (OR=1.49, 95% CI: 1.01, 2.19) and low-lumbar (OR=1.91, 95% CI: 1.18, 3.08) levels of lesion were significantly more likely to have an FSIQ score compared to those with a sacral level of lesion. Individuals with a thoracic level of lesion were less likely to have an FSIQ score compared to those with a sacral level of lesion (OR=0.32, 95% CI: 0.29, 0.94). In analyses stratified by age, functional level of lesion did not remain a consistent significant factor. Distribution of age at IQ (intelligence quotient) test among individuals in the National Spina Bifida Patient Registry (N = 435). Table 2.Multivariable logistic regression analysis of sociodemographic and clinical characteristics associated with having a full-scale intelligence quotient (FSIQ) score in the National Spina Bifida Patient Registry.CharacteristicTotal (N = 863)Aged 4-10 years (N = 509)Aged 11-22 years (N = 354)OR95% CIp-valuen (%)OR a 95% CI a p-valuen (%)OR a 95% CI a p-value Sex Female1.00ref​271 (53)1.00ref​187 (53)1.00ref​ Male1.030.77 to 1.370.85238 (47)0.970.67 to 1.400.86167 (47)1.180.73 to 1.910.51 Race and ethnicity Non-Hispanic White1.00ref​356 (70)1.00ref​222 (63)1.00ref​ Non-Hispanic Black0.910.50 to 1.640.7632 (6.3)0.90.40 to 1.990.7928 (7.9)1.190.46 to 2.970.71 Hispanic or Latino1.120.72 to 1.760.6177 (15)1.610.89 to 2.920.1270 (20)1.020.46 to 2.270.95 Other b 1.030.62 to 1.720.9044 (8.6)1.120.57 to 2.180.7534 (9.6)1.010.42 to 2.340.98 Insurance type Any private1.00ref​266 (52)1.00ref​183 (52)1.00ref​ Non-private c 0.800.59 to 1.080.15243 (48)0.740.50 to 1.090.13171 (48)0.760.45 to 1.260.29 History of academic accommodations d None1.00ref​165 (32)1.00ref​94 (27)1.00ref​ Some1.971.38 to 2.82<0.001**253 (50)2.121.36 to 3.330.001**170 (48)2.181.15 to 4.260.02** Full-time1.831.16 to 2.880.009**91 (18)1.750.96 to 3.210.06790 (25)2.631.22 to 5.800.015** Functional level of lesion Thoracic0.530.29 to 0.940.032**44 (8.6)0.560.25 to 1.230.1654 (15)0.460.18 to 1.120.10 High-lumbar1.70.98 to 2.950.06148 (9.4)1.350.64 to 2.850.4337 (10)1.820.75 to 4.430.19 Mid-lumbar1.491.01 to 2.190.043**178 (35)1.691.03 to 2.790.037**121 (34)1.070.55 to 2.090.85 Low-lumbar1.911.18 to 3.080.008**77 (15)1.790.98 to 3.290.05839 (11)1.70.73 to 3.960.22 Sacral1.00ref​162 (32)1.00ref​103 (29)1.00ref​ History of shunt surgery No1.00ref​ 214 (42)1.00ref​108 (31)1.00ref​ Yes1.120.80 to 1.580.51295 (58)1.320.85 to 2.050.21246 (69)1.190.63 to 2.250.59Note. All models are adjusted for site to account for site-level differences. A total of 27 individuals were removed for missing insurance type and 129 removed for missing academic accommodations.aOR = Odds Ratio, CI = Confidence Interval.bOther race/ethnicity includes Asian, Multiracial, Native Hawaiian or Pacific Islander, and American Indian or Alaskan Native.cNon-private insurance includes public only, supplementary with or without public insurance, and uninsured.dHighest level of academic accommodations ever reported by parent or patient if multiple, “None” refers to patient in all typical/regular education.**p <.05. Multivariable logistic regression analysis of sociodemographic and clinical characteristics associated with having a full-scale intelligence quotient (FSIQ) score in the National Spina Bifida Patient Registry. Note. All models are adjusted for site to account for site-level differences. A total of 27 individuals were removed for missing insurance type and 129 removed for missing academic accommodations. aOR = Odds Ratio, CI = Confidence Interval. bOther race/ethnicity includes Asian, Multiracial, Native Hawaiian or Pacific Islander, and American Indian or Alaskan Native. cNon-private insurance includes public only, supplementary with or without public insurance, and uninsured. dHighest level of academic accommodations ever reported by parent or patient if multiple, “None” refers to patient in all typical/regular education. **p <.05. The mean FSIQ score was 81.3 (standard deviation [SD]: 16.9). Approximately 68% of individuals had FSIQ scores within one SD of the sample mean, with FSIQ scores ranging from 40 to 136 (Figure 3). Twenty-three percent of individuals had an FSIQ score ≤ 70, the cutoff point for intellectual disability, and 13% had an above average (>100) FSIQ score. 19 Among individuals with multiple FSIQ scores, 56 reported having at least two FSIQ scores, and four individuals reported three FSIQ scores (data not shown). Among individuals with two FSIQ scores (n = 56), no significant change was found between the first and second FSIQ scores (t [55] = 1.54, p = 0.129, 95% CI: 0.55, 4.00). Distribution of full-scale intelligence quotient (FSIQ) score among individuals in the National Spina Bifida Patient Registry. Discussion In this study, the sociodemographic and clinical characteristics of individuals with and without FSIQ data in the NSBPR were described and compared. From five sites that collected FSIQ scores, significant differences between individuals with and without reported FSIQ data included age, level of lesion, history of academic accommodation, SB type, history of shunt surgery, and history of shunt infection. Across all age groups, history of academic accommodation was found to be significantly associated with having an FSIQ score when adjusted for sex, race/ethnicity, level of lesion, history of shunt, and clinic. The average age at the time of IQ test administration was 9.7 years, and mean FSIQ score was 81.3. The FSIQ score distribution found in this analysis was lower than in the normative assessment group of the general non-SB population; additionally, the level of discrepancy between the mean scores in the SB sample included in this analysis and the normative average is larger than observed in some other studies.22–25 On average, patients in this sample with an FSIQ score were younger compared to those without. This could be due to the fact that age was defined differently between groups (test age vs. age at last recorded visit). Because differences between younger and older patients were expected, age-stratified modeling was conducted. A higher proportion of individuals with a history of shunt surgery reported FSIQ scores. However, this predictor was not significant in the multivariable model. Individuals with a history of shunt infection, however, had a significantly lower percentage of FSIQ scores reported than those without data (3.7% vs 9.4%, p = 0.015). Also, a higher proportion of children with an FSIQ score had reported academic accommodations. In the multivariable logistic regression model, those with a history of some or full-time academic accommodations were more likely to have an FSIQ score reported. This could be due to a myriad of factors, including that IQ testing is often part of the evaluation for academic accommodation eligibility. Additionally, individuals with thoracic and low-lumbar levels of lesion were more likely to have an IQ test than those with a sacral level of lesion. These findings, however, were not retained in the age-stratified analysis. Other than a participant’s history of academic accommodations, no characteristics were consistently associated with FSIQ score reporting in this sample. Another important finding relates to the age at which the FSIQ score was obtained. The SBA Neuropsychological Guideline for the Care of People with Spina Bifida recommends neurocognitive evaluation, particularly during school age and transition to adulthood.17,26 Younger individuals enrolled in the NSBPR may have had recent experience with early intervention/birth-to-three-year services and may have received testing recommendations to determine eligibility for special education services with the child’s transition into school or to address reports of difficulties in school. Individuals were more likely to have FSIQ data from the ages of four to 10 years than in adolescence. In contrast, few individuals had FSIQ data obtained when transitioning to high school or upon graduation, which is crucial to planning for appropriate adult living needs. This lack of data may reflect the age of the individual when the registry began, loss to follow-up over time, the younger age of individuals in the registry at the sites compared to the general population, lack of access to evaluation, or a change in referral patterns over time. Within the sample of clinics that regularly report FSIQ data, less than half of participants (43%) had reported an FSIQ score. While it is possible that IQ testing was conducted elsewhere or the results were not available to the SB clinic for reporting, the findings suggest many participants may not be undergoing testing. A recent report from the Multisite Neuropsychology Collaborative suggests that multi-lingual SB-focused neuropsychology services are available within all major regions of the US, but that barriers to care include wait lists, cost/insurer coverage, transportation difficulties, and limited referrals. 15 Broadly, having a neuropsychological referral and evaluation can further assess intellectual and specific learning disabilities as well as guide psychosocial interventions and mental health supports. By knowing an individual’s neurocognitive profile, both doctors and educators can be involved in creating informed medical and educational plans for the individual based on their specific needs. An evaluation can also help document a cognitive decline and, at times, assess the need for neurosurgical intervention. Hence, as clinicians appreciate the value of IQ testing, 17 efforts to reduce barriers to accessing these services should be addressed. Limitations While this work represents the first exploration of neurocognitive data for individuals with SB participating in the NSBPR, there are several limitations in the interpretation of these findings as they relate to cognitive functioning for all individuals living with SB. Since the data analyzed are from five NSBPR clinics, it may not be generalizable to all individuals seen in NSBPR clinics or all individuals with SB. Among the NSBPR sites consistently entering FSIQ data, 57% of individuals did not have FSIQ score data entered; furthermore, the source of the data scores (healthcare setting vs school records) was not available. These findings indicate variability regarding cognitive testing and documentation of those results. Further examination of factors that contribute to the likelihood of FSIQ testing among these individuals could provide information helpful for developing treatment plans. Another limitation is that FSIQ scores were derived based on different cognitive assessments; however, assessing the validity of the different measures to assess IQ is beyond the scope of this analysis. Additionally, an FSIQ score alone may not adequately represent the overall ability of individuals with SB, as the more detailed information contained in cognitive domain scores is often necessary to fully understand overall intellectual functioning. This is notable because individuals with SB often display a wide range of performance across different cognitive areas, including fine motor skills, processing speed, visual spatial abilities, executive functions, and verbal factual knowledge.27,28 Overall, the study findings lay the groundwork for future research regarding demographic and clinical factors, intelligence performance, and other functional measures such as adaptive skills and self-management among people with SB. Conclusion The findings show that there are no consistent significant differences between those who had an FSIQ score and those who did not when controlling for potential confounders, with the exception of history of academic accommodations. These NSBPR findings also highlight that individuals with SB have a lower average FSIQ score than individuals in the general population. For this reason, it is important that all individuals with SB are evaluated with IQ testing. In this sample, the only factor predictive of having an FSIQ score among all age groups was a history of having academic accommodations in school. Standardized referral pathways and addressing access barriers may ensure that individuals with SB receive needed IQ testing to identify any issues that may inform clinical care and implementation of services. Additional research on the issues that play a role in cognition and IQ testing could improve the understanding of the barriers to completing these evaluations and modifiable factors that may affect essential neurocognitive functioning across the lifespan for individuals with SB. Acknowledgments This study was funded by the Centers for Disease Control and Prevention under the Cooperative Agreement for Research Approaches to Improve the Care and Outcomes of People Living with Spina Bifida. The authors thank the many individuals with SB and their family members who participated in this research, without whom the NSBPR would not be possible. The NSBPR has also been successful because of the contributions of the Centers for Disease Control and Prevention, the Spina Bifida Association, and all the spina bifida clinics that have been members of the NSBPR Coordinating Committee. Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The National Spina Bifida Patient Registry is funded by the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia by grants DD000738, DD000740, DD000743, DD000774, DD001057, DD001062, DD001065, DD001093, DD001235, DD001237, DD001240, DD001262, DD001265, DD001266, DD001268, DD001270, DD001272, DD001274, DD001275, DD001278, DD001279, and DD001280. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. ORCID iDs Heidi Castillo https://orcid.org/0000-0002-4825-3096 Vanessa Avemil https://orcid.org/0000-0001-5428-8474 Ethical considerations Each participating site obtains local institutional review board approval, and all participants provide written consent prior to enrollment. Consent to participate Each participating site obtains local institutional review board approval, and all participants provide written consent prior to enrollment. Data Availability Statement The data that support the findings of this study are available from the Centers for Disease Control and Prevention but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and within norms of and permission of the Centers for Disease Control and Prevention.* References Associated Data Data Availability Statement The data that support the findings of this study are available from the Centers for Disease Control and Prevention but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and within norms of and permission of the Centers for Disease Control and Prevention.*